LUSPATERCEPT IMPROVES BONE METABOLISM IN THALASSEMIC PATIENTS: A MULTICENTER BIOLOGICAL AND DENSITOMETRIC STUDY (SIE 2026) - Oct 6, 2026 - Abstract #DP070; Pres time: Sep 21, 2026; 07:00 PM - 08:00 PM; Location: AREA POSTER; "The known inhibition of OPG by Lus and a possible consumption of Vitamin D, along with DEXA scan results, are consistent with other findings. Our study suggests that Lus may im- prove bone density and modulates key regulators of bone turnover in TDT patients."
Clinical • Hematological Disorders • PTX3
|
|
G. Cicco1; V. Cecinati2; A. Pasanisi3; R. Renni4; F. Sportelli5; M. Santodirocco6; A. Vitucci7; P. Musto1
|